Sign in

Bruno Beernaert

@brunobeernaert.bsky.social
55 followers 75 following 1 posts
PostsRepliesMedia
Reposted by Bruno Beernaert
Christian Zierhut @zierlab.bsky.social · 21/08/2026
Supremely excited to share our new paper in @natcellbio.nature.com With an updated genetic cGAMP reporter, we reveal that cGAS activation by DNA damage is a rare event, and that cGAS enrichment on intracellular structures cannot be taken as evidence of activation. www.nature.com/articles/s41...
nature.com
A versatile cGAMP reporter reveals principles of cGAS activation by DNA damage and chromosome instability - Nature Cell Biology
Lebrec et al. present a FRET-based cGAS reporter and show that cGAS activation by genotoxic stress is rare and uncoupled from micronuclei. The study implicates R-loop structures and subtypes of chroma...
97030
Reposted by Bruno Beernaert
Centre for Immuno-Oncology @oxcio.bsky.social · 20/05/2026
This Friday, we are carrying out the first CIO Fun Run™️, a non-competitive 5-10K for everyone in our department, with a social drinks and snacks get-together afterwards. We are raising money for #CancerResearchUK @cruk-mi.bsky.social 🏃‍♂️🏃🏾‍♀️🏃🏼‍♀️🏃🏻🏃🏽‍♂️ Donate here: fundraise.cancerresearchuk.org/page/cio-run...
fundraise.cancerresearchuk.org
CIO Run Fun 2026 CRUK Fundraiser
Thanks for taking the time to visit my fundraising page. Cancer is happening right now, which is why I’m fundraising right now for Cancer Research UK. There’s no time to lose! Donate to my page today...
066
Reposted by Bruno Beernaert
Eileen Parkes @eileenparkes.bsky.social · 11/03/2026
Delighted our work on chromosomal instability in oesophageal cancer is now out in Science Advances share.google/UcZXne5OZdM9...
share.google
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS–chemokine–myeloid axis
Chromosomal chaos rewires immune defense into tumor-promoting inflammation.
2165
Reposted by Bruno Beernaert
Waggoner Lab @labwaggoner.bsky.social · 12/03/2026
Chromosomal chaos rewires immune defense into tumor-promoting inflammation www.science.org/doi/10.1126/... @eileenparkes.bsky.social @ox.ac.uk @brunobeernaert.bsky.social
032
Reposted by Bruno Beernaert
Oxford Medical Sciences Division @medsci.ox.ac.uk · 16/03/2026
NEWS: New research reveals why some oesophageal cancers are so hard to treat @oxfordoncology.bsky.social study found that high chromosomal instability is a key feature in most dangerous types.
medsci.ox.ac.uk
New research reveals why some oesophageal cancers are so hard to treat
Research published today in Science Advances has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat and how the body’s own defence systems are helping them to thrive.
055
Reposted by Bruno Beernaert
Oxford Cancer @oxfordcancer.bsky.social · 12/03/2026
New research led by @eileenparkes.bsky.social and co-authored by DPhil in Cancer Science Alumnus, Bruno Beernaert @oncology.ox.ac.uk, has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat. 👇 www.cancer.ox.ac.uk/news/new-res...
cancer.ox.ac.uk
New Research Reveals Why Some Oesophageal Cancers are So Hard to Treat
Research published today in Science Advances has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat and how the body’s own defence systems are helping th...
043
Reposted by Bruno Beernaert
Oxford Cancer @oxfordcancer.bsky.social · 09/02/2026
Our second annual Oesophagogastric Cancer Centre of Excellence Symposium will examine how recent advancements in research and clinical practice are contributing to improved patient outcomes. ✅Open to @ox.ac.uk researchers 📆March 6th, 9am to 5pm Register 👇 www.eventbrite.co.uk/e/oesophagog...
eventbrite.co.uk
Oesophagogastric Cancer Centre of Excellence 2026 Symposium
An event focused on advancing scientific collaboration and improving treatments for oesophagogastric cancer.
123
Reposted by Bruno Beernaert
Oxford Cancer @oxfordcancer.bsky.social · 22/01/2026
Calling all members of the Oxford Cancer Network! A reminder that our Annual Symposium, supported by the CRUK Oxford Centre, is open for registration! When: 31st March Where: @oxfordmathematics.bsky.social Abstracts and register by: 3rd March More 👇 crukcentre.cancer.ox.ac.uk/about/CRUK_o...
012
Reposted by Bruno Beernaert
Christian Zierhut @zierlab.bsky.social · 06/01/2026
Excited to announce a new review article that Andreas Villunger @villungerlab.bsky.social, Dario Rizzotto (not on bsky) and I wrote. In this article, we discuss mitosis as a central cell cycle stage for integrating DNA damage, cell death and inflammatory responses. www.nature.com/articles/s41...
nature.com
Mitotic errors as triggers of cell death and inflammation - Nature Cell Biology
Rizzotto et al. discuss the causes and consequences of deregulated mitosis that allow cells arrested in mitosis to escape to the next interphase, where they can initiate inflammatory signalling or und...
13114
Reposted by Bruno Beernaert
Unterholzner Lab @unterholznerlab.bsky.social · 08/01/2026
We've got a new paper out! In collaboration with @stapleslab.bsky.social @cejkalab.bsky.social @lucyhjackson-j.bsky.social, we show that IFI16 binds to stalled replication forks, protects nascent DNA and mediates an inflammatory response to replication stress. authors.elsevier.com/sd/article/S...
authors.elsevier.com
ScienceDirect.com | Science, health and medical journals, full text articles and books.
163
Reposted by Bruno Beernaert
Matt Jackson @mtjackson101.bsky.social · 05/01/2026
Pre-print alert! We have identified TMEM33 as a novel, intrinsic regulator of CD8+ T cell function and anti-tumor immunity - go check it out. Thanks to all involved!
042
Reposted by Bruno Beernaert
Eileen Parkes @eileenparkes.bsky.social · 05/01/2026
Parkes lab pre-print alert! ‘TMEM33 deletion potentiates anti-tumor CD8⁺ T cell immunity.’ Led by mtjackson101.bsky.social. Full bluetutorial follows! 1/10 www.biorxiv.org/content/10.6...
12310
Reposted by Bruno Beernaert
Nature Reviews Clinical Oncology @natrevclinonc.nature.com · 11/11/2025
nature.com
The biology and therapeutic implications of heterogeneity in Barrett oesophagus and oesophageal adenocarcinoma
Nature Reviews Clinical Oncology, Published online: 11 November 2025; doi:10.1038/s41571-025-01084-0A better understanding of the development and progression of heterogeneity in oesophageal adenocarcinoma and its precursor condition, Barrett oesophagus, is crucial for improving surveillance and treatment strategies. The authors of this Review outline the current knowledge of the causes, mediators and therapeutic implications of spatial and temporal heterogeneity in these diseases.
021
Reposted by Bruno Beernaert
Centre for Immuno-Oncology @oxcio.bsky.social · 09/07/2025
After some cake 🎂 (of course!) to celebrate Tim’s and Nacho’s birthdays 🥳, we wrapped up with fantastic postdoc talks. Big thanks to Bruno, Maria, Lisa and Qian for rounding off a #CIOawayday packed with inspiring science and great company! 😊
072
Reposted by Bruno Beernaert
Christian Zierhut @zierlab.bsky.social · 27/06/2025
Fantastic joint lab meeting day with @eileenparkes.bsky.social and Ben O'Leary plus our groups. Lots of cool science and discussions! And that fancy dinner at Lincoln College!
072
Reposted by Bruno Beernaert
Tim Elliott @timmunologist.bsky.social · 15/05/2025
Real pleasure to see this great piece of work mature over the past few years in @oxcio.bsky.social. Terrific bluetorial!
143
Reposted by Bruno Beernaert
Kadir Akdemir @kcakdemir.bsky.social · 22/05/2025
Excited to share our latest manuscript www.biorxiv.org/content/10.1... This was a great collaboration with Drs. Huse, Lang, @jesserdixon.bsky.social
1156
Reposted by Bruno Beernaert
Wei-Ting Lu @weitinglu.bsky.social · 17/01/2025
We’re thrilled to see our research has been highlighted as the cover of NCB this month 🎉 🎉. We are honoured to share this issue with thought-provoking articles investigating multiple aspects of chromosomal instability and mitosis @dfachinetti.bsky.social @thecesarelab.bsky.social 🧵 1/4
171
Bruno Beernaert @brunobeernaert.bsky.social · 13/05/2025
🚨 Preprint Alert 🚨 Check this out to see how seemingly innocuous errors in cell division can drive an immunosuppressive tumour landscape in this hard-to-treat cancer. With great thanks to all involved!
061
Reposted by Bruno Beernaert
Eileen Parkes @eileenparkes.bsky.social · 12/05/2025
Incoming - new preprint alert from the Parkes lab led by @brunobeernaert.bsky.social Full bluetutorial follows! 1/ 11 www.biorxiv.org/content/10.1...
Model figure - in EAC cancers, as chromosomal instability (CIN) increases, we found that a CIN-driven cGAS-dependent axis drives myeloid directed chemokine expression and recruitment of tumor-favoring myeloid populations
14919
Reposted by Bruno Beernaert
MSK Department of Medicine @mskdeptofmed.bsky.social · 14/03/2025
Congrats to Yelena Janjigian and team on their study in @naturemedicine.bsky.social, which presented biomarker analysis of nivolumab plus chemotherapy or ipilimumab in #gastroesophagealcancer. @mskcancercenter.bsky.social www.nature.com/articles/s41...
nature.com
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial - Nature Medicine
Exploratory biomarker analyses of the phase 3 CheckMate 649 trial show that in patients with advanced gastroesophageal cancer, KRAS alterations were associated with greater overall survival (OS) benef...
0118
Reposted by Bruno Beernaert
Kadir Akdemir @kcakdemir.bsky.social · 28/02/2025
Really excited to share our lab's first manuscript! I cant be more proud of our team, especially @nora-mae.bsky.social who diligently worked on this project. It will be a long thread but I promise it's worth it! #Oncology #BrainMets
1157
Reposted by Bruno Beernaert
Eileen Parkes @eileenparkes.bsky.social · 31/01/2025
Very cool to see my PhD work cited on the timeline of major discoveries in BRCA biology 😎 sparked my joy of discovery which I aim to instill in my students now genesdev.cshlp.org/content/39/1...
genesdev.cshlp.org
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality
A biweekly scientific journal publishing high-quality research in molecular biology and genetics, cancer biology, biochemistry, and related fields
0183
Reposted by Bruno Beernaert
Centre for Immuno-Oncology @oxcio.bsky.social · 31/01/2025
🎂 At @oxcio.bsky.social we take cake seriously... there's even a rota for it! 🍰 Big shoutout to @brunobeernaert.bsky.social & Bas for their recent birthdays! 🥳 Also…look at those cakes 😍🤤
062